These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 16940194)

  • 1. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
    Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
    Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
    Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
    Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
    Mehra MR; Uber PA; Potluri S; Ventura HO; Scott RL; Park MH
    Am J Cardiol; 2004 Aug; 94(4):454-8. PubMed ID: 15325928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.
    Kaski JP; Tomé-Esteban MT; Mead-Regan S; Pantazis A; Marek J; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1307-11. PubMed ID: 18070943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of B-type natriuretic peptide from baseline increases the risk of death or retransplant in pediatric cardiac transplant patients, midterm results.
    Bramlet M; Moore R; Murphy D; Caldwell R; Darragh R; Schamberger M
    Congenit Heart Dis; 2010; 5(3):297-302. PubMed ID: 20576050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Rogers RK; May HT; Anderson JL; Muhlestein JB
    Am Heart J; 2009 Nov; 158(5):777-83. PubMed ID: 19853697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study.
    Law YM; Hoyer AW; Reller MD; Silberbach M
    J Am Coll Cardiol; 2009 Oct; 54(15):1467-75. PubMed ID: 19796740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.
    Holmgren D; Westerlind A; Lundberg PA; Wåhlander H
    Clin Physiol Funct Imaging; 2005 Sep; 25(5):263-9. PubMed ID: 16117728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.
    Detaint D; Messika-Zeitoun D; Avierinos JF; Scott C; Chen H; Burnett JC; Enriquez-Sarano M
    Circulation; 2005 May; 111(18):2391-7. PubMed ID: 15883225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.
    Tang WH; Girod JP; Lee MJ; Starling RC; Young JB; Van Lente F; Francis GS
    Circulation; 2003 Dec; 108(24):2964-6. PubMed ID: 14662703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implication of blood levels of B-type natriuretic peptide in pediatric patients on mechanical circulatory support.
    Huang SC; Wu ET; Ko WJ; Lai LP; Hsu J; Chang CI; Chiu IS; Wang SS; Wu MH; Lin FY; Chen YS
    Ann Thorac Surg; 2006 Jun; 81(6):2267-72. PubMed ID: 16731165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.